NN Investment Partners Holdings’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-80
Closed -$67K 797
2021
Q3
$67K Sell
80
-50
-38% -$50.7K ﹤0.01% 772
2021
Q2
$165K Sell
130
-990
-88% -$1.12M ﹤0.01% 761
2021
Q1
$1.23M Hold
1,120
0.01% 616
2020
Q4
$1.6M Buy
+1,120
New +$1.19M 0.01% 563

Other funds holding CDLX

NN Investment Partners Holdings's CDLX Position: Q4 2021 in Review

NN Investment Partners Holdings sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 80 shares — an estimated $67K sold.

NN Investment Partners Holdings first reported a position in CDLX in Q4 2020 and held it in 4 quarters. The position peaked at $1.6M in Q4 2020. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

  • NN Investment Partners Holdings reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
  • NN Investment Partners Holdings sold 80 Cardlytics shares in Q4 2021, an estimated $67K.
  • NN Investment Partners Holdings first reported a position in Cardlytics in Q4 2020 and held it in 4 quarters.
  • NN Investment Partners Holdings's Cardlytics position peaked at $1.6M in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on NN Investment Partners Holdings's 13F filing for Q4 2021, filed 27 Jan 2022.